Paolo Passoni

Incorporating Individual Early Response in the Dose-Effect Relationship of Complete Pathological Response Following Neoadjuvant Radiochemotherapy for Rectal Cancer

Nab-paclitaxel-gemcitabine met of zonder capecitabine-cisplatine bij pancreascarcinoom: fase II